Neurofilament light chain may be a new blood biomarker to monitor disease severity and response to treatment among people with Friedreich’s ataxia (FA), particularly younger ones, a study suggests. The study, “Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxia,” was published…
Researchers at the College of Health & Life Sciences in London have identified a mechanism that may lead to neurodegeneration in Friedreich’s ataxia (FA) patients, and which could be a possible target for novel gene therapies. Their study, “Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and…
The National Ataxia Foundation (NAF) announced that 20 promising ataxia studies were awarded funding for 2016, and include four Young Investigator SCA Research Awards that provide $50,000, one-year grants to young investigators who are pursuing a career in spinocerebellar ataxia (SCA) research. Among the Young Investigator project winners, Giorgio Grasseli, a post-doctoral student…
The National Ataxia Foundation (NAF) is funding 20 ataxia research studies during 2016, including six projects in the United States, Italy, Canada, United Kingdom and Portugal that were provided for by the foundation’s Research Seed Money Awards. Among the six financially seeded studies, Dr. Paul Rosenberg, an associate professor,…
Get regular updates to your inbox.